News

Viking Therapeutics Announces Participation in Investor Events

Viking Therapeutics Announces Participation in Investor Events

Upcoming Conferences for Viking Therapeutics

Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company specializing in innovative therapies for metabolic and endocrine disorders, is gearing up for participation in a series of important investor conferences. These events are an excellent opportunity for the company to connect with investors and showcase its progress in clinical development.

Details of Conference Participation

The company has outlined several upcoming conferences it intends to attend:

Leerink Partners Global Healthcare Conference 2025

Viking Therapeutics' management will engage in a fireside chat and hold one-on-one meetings with investors. This conference is a crucial forum where key healthcare players discuss industry trends.

Jefferies Biotech on the Beach Summit

This summit will also feature one-on-one meetings with management, allowing for detailed discussions on future directions and innovations.

Exploring Viking's Therapeutic Focus

Viking Therapeutics is deeply committed to developing first-in-class and best-in-class treatments targeting significant metabolic and endocrine disorders. Their impressive pipeline includes three compounds currently in clinical trials, highlighting their dedication to medical advancements.

Among the flagship projects is VK2735, a promising dual agonist aimed at treating various metabolic disorders. The initial results from Phase 1 and Phase 2 trials are encouraging, demonstrating a favorable safety profile along with signs of clinical benefits.

Innovations in Metabolic Health

In addition to VK2735, Viking is also advancing VK2809, a novel small molecule targeting thyroid hormone receptors. This compound has shown significant efficacy in previous studies for conditions like non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), with patients benefiting from reduced liver fat content.

New Programs and Developments

Recently, the company has been expanding its research to develop dual amylin and calcitonin receptor agonists (DACRAs) aimed at combating obesity and other metabolic disorders. They are also exploring VK0214, which targets a rare genetic disorder called X-linked adrenoleukodystrophy (X-ALD), illustrating their commitment to addressing complex health challenges.

Connect with Viking Therapeutics

To stay informed about Viking Therapeutics and their advancements in therapy development, interested parties can explore their website as they frequently update it with the latest information regarding ongoing studies and product launches.

Frequently Asked Questions

What is Viking Therapeutics focused on?

Viking Therapeutics is focused on developing innovative therapies for metabolic and endocrine disorders.

What are the upcoming investor conferences?

Viking Therapeutics will participate in the Leerink Partners Global Healthcare Conference and the Jefferies Biotech on the Beach Summit.

What is VK2735?

VK2735 is a dual agonist targeting GLP-1 and GIP receptors, aimed at treating various metabolic disorders.

Which other compounds are in Viking's pipeline?

Other key compounds include VK2809 and VK0214, targeting lipid and metabolic disorders, and rare diseases, respectively.

How can I find more information about Viking Therapeutics?

You can visit their official website for detailed information about their projects and corporate updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 5

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 2

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Updated Category News Views 4

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 5

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading

Top 5 Most Recently Viewed Articles

Atkore Inc. Set to Showcase Growth at Major Investor Events

Updated Category News Views 166

Atkore Inc. to Join Prominent Investor Conferences Atkore Inc. (NYSE: ATKR), recognized for its leadership in manufacturing electrical products for various sectors, recently shared exciting news of its upcoming participation in several significant investor conferences. These events serve as a pivotal platform for Atkore to engage with investors, showcase its robust...

Continue Reading
CRRC EV Unveils Innovative Electric Buses for Urban Mobility

Updated Category News Views 326

Innovative All-Electric Bus Launch by CRRC EV At the recent Busworld Europe event, CRRC Electric Vehicle Co., Ltd. (CRRC EV) showcased two all-electric buses that signify a major advancement in urban transportation. This launch marks an essential step in CRRC's commitment to sustainable urban mobility, providing cleaner alternatives for public transit. Introducing the...

Continue Reading
JetBlue Expands Horizons with New Routes for Summer Travels

Updated Category News Views 213

JetBlue's Exciting Summer Travel Expansion JetBlue (Nasdaq: JBLU) is making waves in summer travel plans with the introduction of new cities and routes to its growing network. This enhancement aims to provide travelers with an even greater variety of options for their next getaway, whether they are looking for a peaceful coastal retreat, a vibrant city exploration, or a...

Continue Reading
GeoVax Advances Cancer Therapeutics with New Patent Allowance

Updated Category News Views 132

GeoVax Secures Patent for Innovative Cancer Vaccine GeoVax Labs, Inc. (Nasdaq: GOVX), a pioneering biotechnology firm dedicated to developing immunotherapies and vaccines for cancer and infectious diseases, recently announced significant news. The U.S. Patent and Trademark Office has granted a Notice of Allowance for Patent Application No. 17/876,682, titled “Vaccinia...

Continue Reading
TransMedics Enhances Employee Incentives with Stock Grants

Updated Category News Views 148

TransMedics Group, Inc. (NASDAQ: TMDX) announced back in 2024 a strategic push with inducement grants aimed at locking down talent and reinforcing its foothold in the competitive organ transplant space. You’d think after all the turbulence in tech, companies would learn that keeping good people close isn’t just good practice—it's survival. Stock Option Details:...

Continue Reading